Wendy Guy
Founder chez PROCESSA PHARMACEUTICALS, INC.
Fortune : 46 751 $ au 31/03/2024
Profil
Wendy Guy is the founder of Processa Pharmaceuticals, Inc. where she currently holds the title of Chief Administrative Officer since 2017.
Ms. Guy is also the founder of Promet Therapeutics LLC.
Guy's former job includes being a Senior Manager-Business Operation at Questcor Pharmaceuticals, Inc. and a Senior Manager-US Operations at AGI Therapeutics Plc.
Guy's education history includes an undergraduate degree from Mount Wachusett Community College.
Détentions connues dans des sociétés publiques
Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
---|---|---|---|---|
01/01/2024 | 19 768 ( 1,16% ) | 46 751 $ | 31/03/2024 |
Postes actifs de Wendy Guy
Sociétés | Poste | Début |
---|---|---|
PROCESSA PHARMACEUTICALS, INC. | Founder | 29/03/2011 |
Promet Therapeutics LLC
Promet Therapeutics LLC Pharmaceuticals: MajorHealth Technology Promet Therapeutics LLC engage in the clinical stage biotechnology company that develops drug products to treat patients who have suboptimal or no treatment alternatives. The company was founded on September 16, 2015 and is headquartered in Ellicott City, MD. | Founder | - |
Anciens postes connus de Wendy Guy
Sociétés | Poste | Fin |
---|---|---|
QUESTCOR PHARMACEUTICALS INC | Corporate Officer/Principal | - |
AGI Therapeutics Plc
AGI Therapeutics Plc Pharmaceuticals: MajorHealth Technology AGI Therapeutics Plc provides pharmaceutical services. The firm engages in development and commercialization of differentiated drug products to treat unmet medical needs, including conditions which qualify for orphan drug status. The company was founded by John Devane and Patrick Ashe in 2003 and is headquartered in Dublin, Ireland. | Corporate Officer/Principal | - |
Formation de Wendy Guy
Mount Wachusett Community College | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 1 |
---|---|
PROCESSA PHARMACEUTICALS, INC. | Health Technology |
Entreprise privées | 3 |
---|---|
Questcor Pharmaceuticals, Inc.
Questcor Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Questcor Pharmaceuticals, Inc. was engaged in development, marketing and sale of prescription drugs. It operated as a biopharmaceutical company which focuses on the treatment of patients with serious, difficult-to-treat autoimmune and inflammatory disorders. The company's primary product was H.P. Acthar Gel, an injectable drug for the treatment of proteinuria in the nephrotic syndrome of the idiopathic type, or NS, the treatment of acute exacerbations of multiple sclerosis, or MS, in adults, the treatment of infantile spasms, or IS, in infants and children under two years of age, and the treatment of certain rheumatology related conditions, including the treatment of the rare and closely related neuromuscular disorders dermatomyositis and polymyositis. Questcor Pharmaceuticals was founded in September 1992 and was headquartered in Anaheim, CA. | Health Technology |
AGI Therapeutics Plc
AGI Therapeutics Plc Pharmaceuticals: MajorHealth Technology AGI Therapeutics Plc provides pharmaceutical services. The firm engages in development and commercialization of differentiated drug products to treat unmet medical needs, including conditions which qualify for orphan drug status. The company was founded by John Devane and Patrick Ashe in 2003 and is headquartered in Dublin, Ireland. | Health Technology |
Promet Therapeutics LLC
Promet Therapeutics LLC Pharmaceuticals: MajorHealth Technology Promet Therapeutics LLC engage in the clinical stage biotechnology company that develops drug products to treat patients who have suboptimal or no treatment alternatives. The company was founded on September 16, 2015 and is headquartered in Ellicott City, MD. | Health Technology |